AnodyneWiki

Benzydamine

Benzydamine
Benzydamine
Salts
[]
Benzydamine hydrochloride
Benzydamine hydrochloride
Benzydamine salicylate
Benzydamine salicylate
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass309.40 g/mol [1]
Melting point320°F [1]
SolubilityMiscible [1]
Predicted LogP3.9 [1]
Structural Identifiers
[]
Molecular formulaC19H23N3O
IUPAC name3-(1-benzylindazol-3-yl)oxy-N,N-dimethylpropan-1-amine
SMILESCN(C)CCCOC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3
InChIInChI=1S/C19H23N3O/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16/h3-7,9-12H,8,13-15H2,1-2H3
InChIKeyCNBGNNVCVSKAQZ-UHFFFAOYSA-N
CAS number642-72-8
UNII4O21U048EF
PubChem CID12555
Pharmacokinetics[]
Elimination half-life13 hours
ExcretionKidney
Routes of administrationOral, topical

Benzydamine (also known as Benzidamine, Benzindamine, Bencidamina, Benzydaminum, Benzidamina, Apo-Benzydamine, 1-Benzyl-3-(3-(dimethylamino)propoxy)-1H-indazole, 1-Benzyl-3-[3-(dimethylamino)propoxy]-1H-indazole, {3-[(1-benzyl-1H-indazol-3-yl)oxy]propyl}dimethylamine or 1-Propanamine, N,N-dimethyl-3-((1-(phenylmethyl)-1H-indazol-3-yl)oxy)-) is a substance of the benzamide and benzylamine class.

Chemistry

Salts []

Benzydamine is typically found in the form of its hydrochloride and salicylate salts.

 []

Benzydamine is achiral.

Benzydamine matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Despite being categorized as a non-steroidal anti-inflammatory drug (NSAID), benzydamine demonstrates various mechanisms of action that differ from those of traditional aspirin-like NSAIDs. In particular, benzydamine predominantly acts by inhibiting the synthesis of pro inflammatory cytokines like tumour necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β) without largely affecting other pro inflammatory cytokines (ie. such as IL-6 and IL-8) or anti-inflammatory cytokines (ie. like IL-10 or IL-1 receptor antagonist). Moreover, benzydamine is largely a weak inhibitor of prostaglandin synthesis as it has been shown to effectively inhibit cyclooxygenase (COX) and lipoxygenase enzyme activity only at concentrations of 1mM or greater. Considering most contemporary usages of benzydamine are topical applications that are generally not well absorbed through the skin and/or non-specialized mucosae, benzydamine does not often achieve the kind of absorption or blood concentrations necessary to cause any extraneous distant systemic effects or COX inhibition, allowing it to localize its action. Additionally, it is also hypothesized that benzydamine is capable of inhibiting the oxidative burst of neutrophils and membrane stabilization. These actions are exhibited by the substance’s ability to inhibit the release of granules from neutrophils and to stabilize lysosomes. Furthermore, benzydamine is capable of a local anaesthetic effect that may be related to its capability for inhibiting the release of inflammatory mediators like substance P and calcitonin gene related peptide from sensory nerve endings. Since substance P is capable of causing the release of histamine from mast cells, benzydamine’s prevention of substance P release further contributes to an anti-inflammatory effect. Benzydamine also demonstrates a non-specific antibacterial activity against various bacterial strains that are resistant to broad-spectrum antibiotics such as ampicillin, chloramphenicol, and tetracycline at concentrations of about 3 mmol/L. Combinatorial use of benzydamine and other antibiotics like tetracycline and chloramphenicol are also synergistic against antibiotic resistant strains of *Staphylococcus aureus* and *Pseudomonas aeruginosa*. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

shared target3
shared target2

Medical side effects []

10 side effects listed on drug labels in (benzydamine).

  • Hypoaesthesia
  • Sensory loss
  • Pain
  • Vomiting
  • Cough
  • Somnolence
  • Headache
  • Nausea
  • Thirst
  • Throat irritation

Indications

  • Pain
  • Pharyngeal mucositis
  • Throat sore

Experience reports

Erowid

There are currently 10 experience reports involving benzydamine on : []

Reddit

There are currently 1 trip reports involving benzydamine on : []

 []

  • Australia: Benzydamine is a S4 / Schedule 2.[3]
  • Brazil: Benzydamine is a C1.[4]
  • United Kingdom: Benzydamine is a P and Prescription only.[5]
  • European Union: Benzydamine is a OTC.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 12555, Benzydamine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/12555
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Benzydamine. UNII: 4O21U048EF. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/4O21U048EF
  3. Therapeutic Goods (Poisons Standard— June 2025) Instrument 2025. Therapeutic Goods Administration (TGA). May 2025. https://www.legislation.gov.au/F2025L00599/asmade/2025-05-28/text/original/pdf
  4. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
  5. Benzydamine hydrochloride Medicinal forms. BNF. https://bnf.nice.org.uk/drugs/benzydamine-hydrochloride/medicinal-forms/

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 14:40:52
drugspromissing (no DrugsPRO reagent data)2026-11-20 14:40:48
erowidok2026-11-20 14:40:50
gsrsok2026-11-20 14:40:50
hmdbmissing (hmdb.ca refused automated access to HMDB0249061)2026-11-20 14:40:48
keggok2026-11-20 14:40:50
pubchemok2026-11-20 14:40:48
redditok2026-11-20 14:40:48
siderok2026-11-20 14:40:48
structureok2026-11-20 14:40:48
wikipediaok2026-11-20 14:40:48